123 Participants Needed

Ancora-SB Overtube for Small Bowel Disease

Recruiting at 5 trial locations
CS
Overseen ByChris Schultz, BS
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new tool for enteroscopy, a procedure to examine the small bowel. It aims to demonstrate that the Ancora-SB balloon overtube surpasses the Olympus ST-SB1 Balloon Overtube in diagnosing or treating small bowel problems. The trial seeks participants whose video capsule endoscopy (a small camera swallowed like a pill) has revealed issues in the middle part of their small bowel. Those who have not undergone certain surgeries, do not have severe allergies, and can temporarily stop blood-thinning medications may qualify. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance diagnostic tools for small bowel issues.

Will I have to stop taking my current medications?

The trial requires that you stop taking anticoagulant and antiplatelet medications for the procedure. Other medications are not specifically mentioned, so it's best to discuss with the trial team.

What prior data suggests that the Ancora-SB Overtube is safe for small bowel disease?

Research has shown that both the Ancora-SB and the Olympus ST-SB1 overtubes are generally safe for small bowel procedures. Studies indicate that spiral enteroscopy, using devices like the Ancora-SB, is as safe as other methods such as double-balloon enteroscopy, offering a similar safety level with minimal risks. The Ancora-SB overtube features a special micro-textured balloon designed to enhance the procedure's success by reducing slippage.

The Olympus ST-SB1 overtube has undergone thorough testing. Reports have shown it to be safe, with a very low rate of major complications, just 0.4%. Most complications were minor, involving rare small bowel perforations. Additionally, single-balloon enteroscopy, like the ST-SB1, is noted for its safety even in older patients.

Overall, both overtubes are well-tolerated with low risks, making them safe options for those considering participation in clinical trials involving these devices.12345

Why are researchers excited about this trial?

Researchers are excited about using the Ancora-SB Overtube for small bowel disease because it offers a different approach to enteroscopy. Unlike traditional overtubes, the Ancora-SB uses a balloon mechanism that can enhance visualization and access in the small bowel, potentially improving diagnostic and therapeutic outcomes. This method could make procedures more efficient and effective, offering a new hope for patients with challenging small bowel conditions.

What evidence suggests that the Ancora-SB Overtube is effective for small bowel disease?

This trial will compare the Ancora-SB Overtube with the Olympus ST-SB1 Overtube for enteroscopy procedures. Research has shown that the Ancora-SB Overtube might offer advantages due to its design. Its special balloon with a textured surface helps it grip and remain stable during procedures, potentially improving success rates. Current devices like the Olympus overtube succeed only about 50% of the time in certain parts of the bowel.

The Olympus ST-SB1 Overtube has proven effective in many cases, with studies showing a complete examination rate of 73% when used with other methods. Both devices have their advantages, but the Ancora-SB's new features aim to make procedures more consistent and improve patient outcomes.12356

Are You a Good Fit for This Trial?

This trial is for adults aged 18-90 with small bowel disease, who can consent and follow study rules. They must be safe for single balloon enteroscopy (ASA Class I-III) and have lesions in the middle third of the small bowel identified by video capsule endoscopy.

Inclusion Criteria

I am considered low to moderate risk for complications from a specific type of endoscopy.
You are ready and capable of adhering to all study protocols and subsequent assessments.
My small bowel examination showed lesions in the middle part.
See 1 more

Exclusion Criteria

I have had gastric bypass surgery.
Pathology identified by video capsule is in the proximal 1/3 of the bowel
Your doctor expects you to live less than six (6) months.
See 8 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo enteroscopy using either the Ancora-SB or Olympus ST-SB1 Balloon Overtube to identify lesions in the small intestine

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after the enteroscopy procedure

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Enteroscopy
Trial Overview The trial aims to show that the Ancora-SB balloon Overtube is better than the Olympus ST-SB1 Balloon Overtube during endoscopic procedures for viewing and positioning within the small intestine.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: Ancora-SB OvertubeActive Control1 Intervention
Group II: Olympus ST-SB1 OvertubeActive Control1 Intervention

Enteroscopy is already approved in United States, European Union, Japan for the following indications:

🇺🇸
Approved in United States as Enteroscopy for:
🇪🇺
Approved in European Union as Enteroscopy for:
🇯🇵
Approved in Japan as Enteroscopy for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Aspero Medical, Inc.

Lead Sponsor

Trials
1
Recruited
120+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Published Research Related to This Trial

The Discovery SB overtube allows for safe and effective advancement of the enteroscope into the distal small bowel, with no reported perforations and low trauma scores in the majority of patients during procedures performed by inexperienced endoscopists.
After just five training cases, the endoscopists achieved a significant increase in depth of insertion from day 1 to day 2, indicating that the device is user-friendly and can lead to improved performance with minimal training.
The spiral enteroscopy training initiative: results of a prospective study evaluating the Discovery SB overtube device during small bowel enteroscopy (with video).Buscaglia, JM., Dunbar, KB., Okolo, PI., et al.[2022]
Double balloon enteroscopy is a safe and effective technique for examining the small bowel in patients with suspected bleeding, allowing for complete examination and therapeutic interventions.
Single balloon enteroscopy and a novel overtube device also show promise in deep enteroscopy, providing viable alternatives that can access areas of the small bowel previously only reachable through surgery.
Small bowel enteroscopy.Upchurch, BR., Vargo, JJ.[2012]
In a study of 523 patients undergoing retrograde enteroscopy, double-balloon enteroscopy (DBE) demonstrated a significantly shorter procedure time (26.5 minutes) compared to single-balloon enteroscopy (SBE) (34.8 minutes), indicating greater efficiency.
DBE also achieved a greater depth of insertion (108.1 cm) compared to SBE (73.3 cm), while both techniques showed similar rates of technical success and diagnostic yield, suggesting that DBE may be a more effective option for certain procedures.
Efficacy and safety of double- versus single-balloon retrograde enteroscopy.Garg, R., Singh, A., Mohammed, A., et al.[2023]

Citations

Ancora-SB Overtube for Small Bowel DiseaseTrial Overview The trial aims to show that the Ancora-SB balloon Overtube is better than the Olympus ST-SB1 Balloon Overtube during endoscopic procedures for ...
Ancora-SB Overtube During Endoscopic Procedures (Small ...The purpose of this study is to evaluate the Aspero Medical, Inc. Ancora-SB (single balloon) overtube device as a possible technology for the diagnosis.
Rentschler, Aspero Medical awarded $4.5M for endoscopy ...Equipped with a patented micro-textured balloon, the Ancora-SB overtube is designed to provide more traction and anchoring consistency than ...
Project Details - NIH RePORTERSuccess rates in this portion of the bowel with current devices, including the Olympus overtube, are estimated to be about 50%. Market research indicates ...
First Patient Enrollment into Aspero Medical NIH-Funded ...Balloon enteroscopy has become the standard of care in the drive to diagnose and treat small bowel disease. Unlike the Ancora-SB balloon made by ...
Ancora-SB Overtube Complete Positioning and Optical ...The study objective, demonstrate superiority of the Aspero Ancora-SB balloon overtube compared to the Olympus ST-SB1 Balloon Overtube, is necessary for ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security